APPEL RONI sold 22.3% of their position (3K shares) of AYALA PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $1.7K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 3/16/2020ACC: 0001493152-20-004065
-3K
Net shares
Net seller
$1.7K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
3K disposed
Non-Derivative Transactions3
Common Stock
Indirect
Shares
−399.00
Price / share
$0.67
Trade value
$267.33
% of position
3.0%
3/11/2020
13.48K→13.08K
Common Stock
Indirect
Shares
−200.00
Price / share
$0.58
Trade value
$116.00
% of position
1.5%
3/12/2020
13.08K→12.88K
Common Stock
Indirect
Shares
−2.40K
Price / share
$0.55
Trade value
$1.32K
% of position
18.6%
3/13/2020
12.88K→10.48K
Total
Net shares
−3K
Net value
-$1.70K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 3/11/2020 | S · Sale | −399.00 | $0.67 | $267.33 | 3.0% | 13.48K | 13.08K |
| Common Stock Indirect | 3/12/2020 | S · Sale | −200.00 | $0.58 | $116.00 | 1.5% | 13.08K | 12.88K |
| Common Stock Indirect | 3/13/2020 | S · Sale | −2.40K | $0.55 | $1.32K | 18.6% | 12.88K | 10.48K |
| Total | −3K | -$1.70K | ||||||
Derivative Transactions0
No derivative transactions reported